As of 2026-01-07, the EV/EBITDA ratio of Exagen Inc (XGN) is -15.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 161.72 mil USD. XGN's TTM EBITDA according to its financial statements is -10.55 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.9x - 8.1x | 7.5x |
| Forward P/E multiples | 5.5x - 10.0x | 7.8x |
| Fair Price | (2.24) - (2.72) | (2.54) |
| Upside | -136.8% - -144.6% | -141.8% |
| Date | EV/EBITDA |
| 2026-01-02 | -15.20 |
| 2025-12-31 | -15.31 |
| 2025-12-30 | -15.12 |
| 2025-12-29 | -15.04 |
| 2025-12-26 | -15.44 |
| 2025-12-24 | -15.60 |
| 2025-12-23 | -15.95 |
| 2025-12-22 | -16.78 |
| 2025-12-19 | -16.24 |
| 2025-12-18 | -16.35 |
| 2025-12-17 | -16.19 |
| 2025-12-16 | -17.10 |
| 2025-12-15 | -17.84 |
| 2025-12-12 | -18.05 |
| 2025-12-11 | -18.32 |
| 2025-12-10 | -18.13 |
| 2025-12-09 | -17.81 |
| 2025-12-08 | -17.73 |
| 2025-12-05 | -18.29 |
| 2025-12-04 | -19.07 |
| 2025-12-03 | -18.51 |
| 2025-12-02 | -18.03 |
| 2025-12-01 | -19.09 |
| 2025-11-28 | -20.16 |
| 2025-11-26 | -19.73 |
| 2025-11-25 | -19.63 |
| 2025-11-24 | -19.25 |
| 2025-11-21 | -19.39 |
| 2025-11-20 | -19.81 |
| 2025-11-19 | -20.19 |
| 2025-11-18 | -20.99 |
| 2025-11-17 | -21.68 |
| 2025-11-14 | -23.12 |
| 2025-11-13 | -24.02 |
| 2025-11-12 | -24.66 |
| 2025-11-11 | -23.68 |
| 2025-11-10 | -24.32 |
| 2025-11-07 | -24.58 |
| 2025-11-06 | -26.77 |
| 2025-11-05 | -26.64 |
| 2025-11-04 | -27.81 |
| 2025-11-03 | -30.63 |
| 2025-10-31 | -30.21 |
| 2025-10-30 | -30.45 |
| 2025-10-29 | -30.69 |
| 2025-10-28 | -30.79 |
| 2025-10-27 | -30.85 |
| 2025-10-24 | -30.98 |
| 2025-10-23 | -30.87 |
| 2025-10-22 | -30.42 |